JNJ-7528 / J&J - LARVOL DELTA

READY-AD: A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis (clinicaltrials.gov) - P2 | N=189 | Active, not recruiting | Sponsor: Janssen Research & Development, LLC | Recruiting ➔ Active, not recruiting

Enrollment closed • Atopic Dermatitis • Dermatitis • Dermatology • Immunology

READY-BREATHE: A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma (clinicaltrials.gov) - P2 | N=440 | Not yet recruiting | Sponsor: Janssen Research & Development, LLC

New P2 trial • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases

95597528ADM2001: A Study of JNJ-95597528 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (clinicaltrialsregister.eu) - P1/2 | N=7 | Not yet recruiting | Sponsor: Janssen Cilag International

New P1/2 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology

A Study of JNJ-95597528 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (ChiCTR) - P=N/A | N=180 | Sponsor: China-Japan Friendship Hospital; China-Japan Friendship Hospital

New trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology

READY-AD: A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis (clinicaltrials.gov) - P2 | N=180 | Recruiting | Sponsor: Janssen Research & Development, LLC | Not yet recruiting ➔ Recruiting

Enrollment open • Atopic Dermatitis • Dermatitis • Dermatology • Immunology

A Single Ascending Dose/Multiple Ascending Dose Study of JNJ-95597528 in Healthy Participants and a Proof of Mechanism Study in Participants with Mild to Moderate Asthma (ANZCTR) - P1 | N=76 | Recruiting | Sponsor: Janssen Research & Development, LLC | Not yet recruiting ➔ Recruiting

Enrollment open • First-in-human • Asthma • Atopic Dermatitis • Dermatitis • Dermatology • Immunology • Pulmonary Disease • Respiratory Diseases

READY-AD: A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis (clinicaltrials.gov) - P2 | N=180 | Not yet recruiting | Sponsor: Janssen Research & Development, LLC

New P2 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology